XML 17 R5.htm IDEA: XBRL DOCUMENT v3.19.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2019
Mar. 31, 2019
Jun. 30, 2018
Mar. 31, 2018
Jun. 30, 2019
Jun. 30, 2018
Dec. 31, 2018
Dec. 31, 2017
Cash and Cash Equivalents [Line Items]                
Repayments of Lines of Credit         $ 350,000 $ 0    
Document Period End Date         Jun. 30, 2019      
Payments of Debt Issuance Costs         $ (3,701) 0    
Cash, Cash Equivalents and Restricted Cash         814,781 787,159 $ 777,596 $ 824,088
Cash flows from operating activities:                
Net income $ 92,593 $ 113,896 $ 73,922 $ 90,828 206,489 164,750    
Adjustments to reconcile net income to net cash provided by operating activities:                
Amortization 25,954   20,785   52,146 41,324    
Depreciation 5,666   5,599   11,701 11,151    
Non-cash stock-based compensation         24,128 15,027    
Change in estimated acquisition earn-out payables (2,860)   419   (1,650) 2,885    
Deferred income taxes         (5,342) (16,437)    
Amortization of debt discount and disposal of deferred financing costs         988 819    
Accretion (Amortization) of Discounts and Premiums, Investments         (12) 1    
Payments On Acquisition Earn Outs In Excess Of Original Estimated Payables         (267) (3,408)    
Net gain/(loss) on sales of investments, fixed assets and customer accounts         (346) (2,432)    
Changes in operating assets and liabilities, net of effect from acquisitions and divestitures:                
Premiums, commissions and fees receivable (increase) decrease         (71,614) (29,471)    
Reinsurance recoverables (increase) decrease         (11,939) 388,704    
Prepaid reinsurance premiums (increase) decrease         (5,674) 10,310    
Other assets (increase) decrease         (22,122) (15,731)    
Premiums payable to insurance companies increase (decrease)         116,472 106,839    
Premium deposits and credits due customers increase (decrease)         (12,003) 8,360    
Losses and loss adjustment reserve increase (decrease)         12,123 (388,572)    
Unearned premiums increase (decrease)         5,674 (10,310)    
Accounts payable increase (decrease)         23,773 31,343    
Accrued expenses and other liabilities increase (decrease)         (32,269) (34,837)    
Other liabilities increase (decrease)         15,447 (2,909)    
Net cash provided by operating activities         305,703 277,406    
Cash flows from investing activities:                
Additions to fixed assets (11,988)   (9,639)   (35,174) (19,390)    
Payments for businesses acquired, net of cash acquired         (146,646) (141,803)    
Proceeds from sales of fixed assets and customer accounts         2,101 2,906    
Purchases of investments         (9,265) (8,863)    
Proceeds from Sale, Maturity and Collection of Investments         4,505 16,346    
Net cash used in investing activities         (184,479) (150,804)    
Cash flows from financing activities:                
Payments on acquisition earn-outs         (6,997) (5,183)    
Proceeds from Issuance of Long-term Debt         350,000 0    
Payments on long-term debt         (22,500) (110,001)    
Issuances of common stock for employee stock benefit plans         901 720    
Repurchase Of Stock Benefit Plan Shares For Employees To Fund Tax Withholdings         (6,861) (7,656)    
Purchase of treasury stock         (20,000) (11,250)    
Settlement (prepayment) of accelerated share repurchase program         20,000 11,250    
Cash dividends paid         (44,881) (41,411)    
Net cash used in financing activities         (84,039) (163,531)    
Cash and cash equivalents inclusive of restricted cash at end of period 432,548   477,928   432,548 477,928 438,961 573,383
Cash and Cash Equivalents inclusive of Restricted Cash [Member]                
Cash flows from financing activities:                
Net increase (decrease) in cash and cash equivalents inclusive of restricted cash         37,185 (36,929)    
Cash and cash equivalents inclusive of restricted cash at end of period $ 814,781   $ 787,159   $ 814,781 $ 787,159 $ 777,596 $ 824,088